IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v46y2023i5d10.1007_s40264-023-01291-7.html
   My bibliography  Save this article

Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project

Author

Listed:
  • Jonathan L. Richardson

    (Newcastle upon Tyne Hospitals NHS Foundation Trust
    Newcastle University)

  • Alan Moore

    (Novartis Pharma AG)

  • Rebecca L. Bromley

    (University of Manchester
    Royal Manchester Children’s Hospital)

  • Michael Stellfeld

    (Novo Nordisk A/S)

  • Yvonne Geissbühler

    (Novartis Pharma AG)

  • Matthew Bluett-Duncan

    (University of Manchester)

  • Ursula Winterfeld

    (University Hospital)

  • Guillaume Favre

    (University Hospital)

  • Amalia Alexe

    (Novartis Pharma AG)

  • Alison M. Oliver

    (Newcastle upon Tyne Hospitals NHS Foundation Trust)

  • Yrea R. J. Rijt-Weetink

    (Pharmacovigilance Centre Lareb)

  • Kenneth K. Hodson

    (Newcastle upon Tyne Hospitals NHS Foundation Trust)

  • Bita Rezaallah

    (Novartis Pharma AG)

  • Eugene P. Puijenbroek

    (Pharmacovigilance Centre Lareb
    University of Groningen)

  • David J. Lewis

    (Novartis Pharma GmbH
    University of Hertfordshire)

  • Laura M. Yates

    (University of KwaZulu-Natal
    Newcastle upon Tyne Hospitals NHS Foundation Trust)

Abstract

Introduction and Objective The risks and benefits of medication use in pregnancy are typically established through post-marketing observational studies. As there is currently no standardised or systematic approach to the post-marketing assessment of medication safety in pregnancy, data generated through pregnancy pharmacovigilance (PregPV) research can be heterogenous and difficult to interpret. The aim of this article is to describe the development of a reference framework of core data elements (CDEs) for collection in primary source PregPV studies that can be used to standardise data collection procedures and, thereby, improve data harmonisation and evidence synthesis capabilities. Methods This CDE reference framework was developed within the Innovative Medicines Initiative (IMI) ConcePTION project by experts in pharmacovigilance, pharmacoepidemiology, medical statistics, risk–benefit communication, clinical teratology, reproductive toxicology, genetics, obstetrics, paediatrics, and child psychology. The framework was produced through a scoping review of data collection systems used by established PregPV datasets, followed by extensive discussion and debate around the value, definition, and derivation of each data item identified from these systems. Results The finalised listing of CDEs comprises 98 individual data elements, arranged into 14 tables of related fields. These data elements are openly available on the European Network of Teratology Information Services (ENTIS) website ( http://www.entis-org.eu/cde ). Discussion With this set of recommendations, we aim to standardise PregPV primary source data collection processes to improve the speed at which high-quality evidence-based statements can be provided about the safety of medication use in pregnancy.

Suggested Citation

  • Jonathan L. Richardson & Alan Moore & Rebecca L. Bromley & Michael Stellfeld & Yvonne Geissbühler & Matthew Bluett-Duncan & Ursula Winterfeld & Guillaume Favre & Amalia Alexe & Alison M. Oliver & Yrea, 2023. "Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project," Drug Safety, Springer, vol. 46(5), pages 479-491, May.
  • Handle: RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01291-7
    DOI: 10.1007/s40264-023-01291-7
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-023-01291-7
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-023-01291-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. R. A. Charlton & A. McGrogan & J. Snowball & L. M. Yates & A. Wood & J. Clayton-Smith & W. H. Smithson & J. L. Richardson & N. McHugh & S. H. L. Thomas & G. A. Baker & R. Bromley, 2017. "Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort," Drug Safety, Springer, vol. 40(5), pages 387-397, May.
    2. Saskia Vorstenbosch & Bernke Winkel & Marleen M. H. J Gelder & Agnes Kant & Nel Roeleveld & Eugène Puijenbroek, 2019. "Aim and Design of pREGnant, the Dutch Pregnancy Drug Register," Drug Safety, Springer, vol. 42(1), pages 1-12, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Michael Ceulemans & Kristel Van Calsteren & Karel Allegaert & Veerle Foulon, 2022. "Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare Professionals," IJERPH, MDPI, vol. 19(14), pages 1-14, July.
    2. Alana Cavadino & Lovisa Sandberg & Inger Öhman & Tomas Bergvall & Kristina Star & Helen Dolk & Maria Loane & Marie-Claude Addor & Ingeborg Barisic & Clara Cavero-Carbonell & Ester Garne & Miriam Gatt , 2021. "Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference," Drug Safety, Springer, vol. 44(7), pages 765-785, July.
    3. Annerose E. van der Mijle & Petra J. Woestenberg & Leanne J. Kosse & Eugène P. van Puijenbroek, 2023. "The Dutch Pregnancy Drug Register: Suitable to Study Paternal Drug Exposures?," IJERPH, MDPI, vol. 20(23), pages 1-9, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01291-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.